Helmut Albrecht to Treatment Outcome
This is a "connection" page, showing publications Helmut Albrecht has written about Treatment Outcome.
Connection Strength
0.142
-
Patient-reported outcomes to assess the efficacy of extended-release guaifenesin for the treatment of acute respiratory tract infection symptoms. Respir Res. 2012 Dec 27; 13:118.
Score: 0.046
-
Co-formulated bictegravir, emtricitabine, and tenofovir alafenamide versus dolutegravir with emtricitabine and tenofovir alafenamide for initial treatment of HIV-1 infection: week 96 results from a randomised, double-blind, multicentre, phase 3, non-inferiority trial. Lancet HIV. 2019 06; 6(6):e364-e372.
Score: 0.018
-
Combination therapy vs. monotherapy for Gram-negative bloodstream infection: matching by predicted prognosis. Int J Antimicrob Agents. 2018 Mar; 51(3):488-492.
Score: 0.016
-
The South Carolina rural-urban HIV continuum of care. AIDS Care. 2017 07; 29(7):817-822.
Score: 0.015
-
Prediction of Fluoroquinolone Resistance in Gram-Negative Bacteria Causing Bloodstream Infections. Antimicrob Agents Chemother. 2016 Apr; 60(4):2265-72.
Score: 0.014
-
The South Carolina HIV Cascade of Care. South Med J. 2015 Nov; 108(11):670-4.
Score: 0.014
-
Stratification of the impact of inappropriate empirical antimicrobial therapy for Gram-negative bloodstream infections by predicted prognosis. Antimicrob Agents Chemother. 2015 Jan; 59(1):245-50.
Score: 0.013
-
Early correction of cell cycle perturbations predicts the immunological response to therapy in HIV-infected patients. AIDS. 2004 Feb 20; 18(3):393-402.
Score: 0.006